PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan. yohei@med.kobe-u.ac.jp.\', \'Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan.\', \'Division of Infection Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan.\', \'R&D, Cellspect Co., Ltd, Morioka, Iwate, Japan.\', \'BioResource Center, Kobe University Hospital, Kobe, Japan.\', \'Division of Molecular and Cellular Signaling, Kobe University Graduate School of Medicine, Kobe, Japan.\', \'Department of Transfusion Medicine and Cell Therapy, Kobe University Hospital, Kobe, Japan.\', \'Division of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan.\', \'Cancer Center, Kobe University Hospital, Kobe, Japan.\', \'Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s12185-021-03247-y
?:hasPublicationType
?:journal
  • International journal of hematology
is ?:pmid of
?:pmid
?:pmid
  • 34981433
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.76
?:rankingScore_hIndex
  • 66
is ?:relation_isRelatedTo_publication of
?:title
  • Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all